2021 OTS Lifetime Achievement Award Winner C. Frank Bennett, PhD

September 16th, 2020|Categories: Lifetime Achievement Award|

Frank Bennett, Ph.D. Ionis Pharmaceuticals Dr. Bennett is the executive vice president and chief scientific officer at Ionis Pharmaceuticals and one of the founding members of the company. He is responsible for continuing to advance antisense technology and expanding Ionis drug discovery platform. Dr. ...

Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia

September 9th, 2020|Categories: Antisense/RNase H, Clinical Development|

Gaudet D, Karwatowska-Prokopczuk E, Baum SJ, Hurh E, Kingsbury J, Bartlett VJ, Figueroa AL, Piscitelli P, Singleton W, Witztum JL, Geary RS, Tsimikas S, St L O'Dea L. Eur Heart J. 2020 Aug 29:ehaa689. Pubmed

Convective forces increase rostral delivery of intrathecal radiotracers and antisense oligonucleotides in the cynomolgus monkey nervous system.

September 9th, 2020|Categories: Antisense/RNase H, Delivery, Immunostimulation, Pre-Clinical Research, Toxicology|

Sullivan JM, Mazur C, Wolf DA, Horky L, Currier N, Fitzsimmons B, Hesterman J, Pauplis R, Haller S, Powers B, Tayefeh L, DeBrosse-Serra B, Hoppin J, Kordasiewicz H, Swayze EE, Verma A. J Transl Med. 2020 Aug 8;18(1):309. Pubmed

Go to Top